These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37034526)

  • 1. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.
    Lind A; Azizy O; Lortz J; Janosi A; Rassaf T; Rammos C
    Arch Med Sci; 2023; 19(2):331-336. PubMed ID: 37034526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation.
    Kebernik J; Jose J; Abdel-Wahab M; Stöcker B; Geist V; Richardt G
    Cardiol Ther; 2015 Dec; 4(2):167-77. PubMed ID: 26563411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation.
    Wintgens LIS; Vorselaars VMM; Klaver MN; Swaans MJ; Alipour A; Rensing BJWM; Post MC; Boersma LVA
    Neth Heart J; 2019 Dec; 27(12):613-620. PubMed ID: 31187455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.
    Basabe E; De La Flor JC; López de la Manzanara V; Nombela-Franco L; Narváez-Mejía C; Cruzado L; Villa D; Zamora R; Tapia M; Sastre MÁ; López Soberón E; Herrero Calvo JA; Suárez A; Martí Sánchez D
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation.
    Saw J; Bennell MC; Singh SM; Wijeysundera HC
    Can J Cardiol; 2016 Nov; 32(11):1355.e9-1355.e14. PubMed ID: 27432692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).
    Wang Y; Wu D; Ma J; Liu X; Zhang H; So CY; Lam YY; Wang B; Wang J; Zhang H; Wang M; Song G; Wu Y
    Am J Cardiovasc Dis; 2021; 11(5):679-687. PubMed ID: 34849300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2021 Aug; ():. PubMed ID: 34362613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of CHA
    Tarantini G; D'Amico G; Schmidt B; Mazzone P; Berti S; Fischer S; Lund J; Montorfano M; Della Bella P; Lam SCC; Cruz-Gonzalez I; Gage R; Zhao H; Omran H; Odenstedt J; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2020 Sep; 13(18):2099-2108. PubMed ID: 32972570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
    Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
    Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation.
    Liu J; Xia Y; Zhang H; Li X; Zhang S; Fang P
    Herz; 2021 Apr; 46(Suppl 1):82-88. PubMed ID: 32002565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Extended Utility of CHA
    Streb W; Mitręga K; Morawski S; Kowalska W; Kalarus Z
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.